Wakefield Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-17,105
Closed -$960K 173
2021
Q3
$960K Sell
17,105
-361
-2% -$19.8K 0.36% 75
2021
Q2
$910K Buy
17,466
+38
+0.2% +$1.82K 0.34% 85
2021
Q1
$768K Buy
17,428
+6,411
+58% +$269K 0.31% 104
2020
Q4
$384K Sell
11,017
-61
-0.6% -$2.17K 0.16% 136
2020
Q3
$403K Buy
11,078
+70
+0.6% +$2.6K 0.19% 130
2020
Q2
$413K Buy
+11,008
New +$440K 0.2% 134

Other funds holding PBH

Wakefield Asset Management's PBH Position: Q4 2021 in Review

Wakefield Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2021, closing a stake of 17,105 shares — an estimated $960K sold.

Wakefield Asset Management first reported a position in PBH in Q2 2020 and held it in 6 quarters. The position peaked at $960K in Q3 2021. 272 funds tracked by Wall St. Rank hold PBH as of Q4 2021.

  • Wakefield Asset Management reported no remaining Prestige Consumer Healthcare position as of Q4 2021 after selling out during the quarter.
  • Wakefield Asset Management sold 17,105 Prestige Consumer Healthcare shares in Q4 2021, an estimated $960K.
  • Wakefield Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2020 and held it in 6 quarters.
  • Wakefield Asset Management's Prestige Consumer Healthcare position peaked at $960K in Q3 2021.
  • 272 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2021.

Based on Wakefield Asset Management's 13F filing for Q4 2021, filed 1 Feb 2022.